Literature DB >> 3181812

Immune function in malignant cervical neoplasia: a multiparameter analysis.

P Balaram1, M R Pillai, T K Padmanabhan, T Abraham, N K Hareendran, M K Nair.   

Abstract

Immunological assessment was carried out in 67 patients with various stages and histological grades of squamous cell carcinoma of the uterine cervix and compared with normal controls to discover whether any of these parameters could be used as an indicator of the patient's clinical status. The results show a gross impairment of the various lymphocyte subpopulations and anti-tumor immunity. This impairment was more pronounced in patients with high tumor load and having a histology of poorly differentiated squamous cell carcinomas. None of the parameters studied (total leukocyte numbers, lymphocyte subpopulations, leukocyte adherence inhibition test, natural killer cell activity, circulating immune complexes, and blocking effect of autologous serum) could be used as a clinical indicator, since no correlation could be noted between immune impairment and either the lymphocyte subpopulations or the circulating immune complexes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181812     DOI: 10.1016/s0090-8258(88)80025-8

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach.

Authors:  Susan K Lutgendorf; Elizabeth Mullen-Houser; Daniel Russell; Koen Degeest; Geraldine Jacobson; Laura Hart; David Bender; Barrie Anderson; Thomas E Buekers; Michael J Goodheart; Michael H Antoni; Anil K Sood; David M Lubaroff
Journal:  Brain Behav Immun       Date:  2010-06-30       Impact factor: 7.217

2.  A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.

Authors:  A G Bais; I Beckmann; J Lindemans; P C Ewing; C J L M Meijer; P J F Snijders; T J M Helmerhorst
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

3.  Interferon and interleukin-2 induced spontaneous cell-mediated cytotoxicity: a preliminary evaluation.

Authors:  P Balaram; M R Pillai; T Abraham; K R Nalinakumari; G Meenattoor; S Kannan; N K Hareendran; M K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Immune reactive proteins as prognostic and clinical markers in malignant cervical neoplasia.

Authors:  M Radhakrishna Pillai; P Balaram; N K Hareendran; S Bindu; T Abraham; T K Padmanabhan; M K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.